Evaluation of Safety and Effectiveness on Oral Anticoagulants

Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study

NCT00526136 ·Status: COMPLETED ·Phase: PHASE2

Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation

NCT05039359 ·Status: TERMINATED ·Phase: PHASE3

Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation

NCT05469308 ·Status: UNKNOWN ·Phase: NA

Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation

NCT02623049 ·Status: UNKNOWN

Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

NCT06108414 ·Status: RECRUITING ·Phase: PHASE4

Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation

NCT04684056 ·Status: UNKNOWN

Safety of Single Intravenous Administration of S95010 in Human Healthy Volunteers

NCT03494712 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)

NCT00568594 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

DOAC in Chinese Patients With Atrial Fibrillation

NCT05378035 ·Status: RECRUITING

Efficacy and Safety Study of F373280

NCT01831856 ·Status: COMPLETED ·Phase: PHASE2

Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

NCT04747496 ·Status: COMPLETED

A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)

NCT02069119 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure

NCT01877915 ·Status: COMPLETED ·Phase: PHASE3

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

NCT03285373 ·Status: COMPLETED

Exploring the Efficacy of Once Daily Oral Rivaroxaban for Treatment of Thrombus in Left Atrial/Left Atrial Appendage in Subjects With Nonvalvular Atrial Fibrillation or Atrial Flutter

NCT01839357 ·Status: COMPLETED ·Phase: PHASE3

This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain

NCT03993119 ·Status: COMPLETED

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

NCT06953726 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Population Pharmacokinetics of Edoxaban in Chinese Patients With Non-Valvular Atrial Fibrillation

NCT05320627 ·Status: COMPLETED ·Phase: PHASE4

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation

NCT01483183 ·Status: TERMINATED ·Phase: PHASE1

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

NCT05724121 ·Status: RECRUITING

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

NCT00353522 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Sulcardine Sulfate Tablets in Patients With Premature Ventricular Contractions

NCT01235156 ·Status: UNKNOWN

A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

NCT05414175 ·Status: COMPLETED ·Phase: PHASE3

Safety, PK, and Efficacy of Omecamtiv Mecarbil in Japanese Subjects With Heart Failure With Reduced Ejection Fraction

NCT02695420 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

NCT04907825 ·Status: COMPLETED ·Phase: PHASE4